...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Td waterhouse
3
Sep 07, 2018 09:53AM
2
Sep 07, 2018 10:27AM
5
Sep 07, 2018 10:45AM
2
Sep 07, 2018 11:01AM
3
Sep 07, 2018 11:04AM
6
Sep 07, 2018 12:10PM

Not sure where these Rumours are coming from other than the discussion LED had with DM at the bloom and burton conference this past May but Zenith just completed a PP at $2usd so that’s pretty low if a buyout is in the works at $10 to $15 usd  anything is possible i suppose

 


Sep 08, 2018 04:33PM
Share
New Message
Please login to post a reply